| __timestamp | Incyte Corporation | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 9757000 |
| Thursday, January 1, 2015 | 753751000 | 1253000 |
| Friday, January 1, 2016 | 1105719000 | 5421000 |
| Sunday, January 1, 2017 | 1536216000 | 154584000 |
| Monday, January 1, 2018 | 1881883000 | 301034000 |
| Tuesday, January 1, 2019 | 2158759000 | 380833000 |
| Wednesday, January 1, 2020 | 2666702000 | 540099000 |
| Friday, January 1, 2021 | 2986267000 | 701887000 |
| Saturday, January 1, 2022 | 3394635000 | 933013000 |
| Sunday, January 1, 2023 | 3695649000 | 1243336000 |
| Monday, January 1, 2024 | 4241217000 |
Unleashing insights
In the competitive landscape of biotechnology, Incyte Corporation and Sarepta Therapeutics, Inc. have been pivotal players. Over the past decade, Incyte has consistently outperformed Sarepta in terms of revenue growth. Starting in 2014, Incyte's revenue was approximately 52 times that of Sarepta's. By 2023, Incyte's revenue surged to nearly 3.7 billion, marking a 622% increase from 2014, while Sarepta's revenue grew to 1.24 billion, a staggering 12,600% increase from its modest beginnings. This growth trajectory highlights Incyte's steady expansion and Sarepta's rapid catch-up. The data underscores the dynamic nature of the biotech industry, where innovation and strategic investments drive financial success. As both companies continue to innovate, the coming years will be crucial in determining who will lead the revenue race.
Revenue Insights: Pfizer Inc. and Sarepta Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Incyte Corporation?
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Revenue Insights: Genmab A/S and Sarepta Therapeutics, Inc. Performance Compared
Breaking Down Revenue Trends: Incyte Corporation vs BioMarin Pharmaceutical Inc.
Incyte Corporation vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Incyte Corporation and Bausch Health Companies Inc. Performance Compared
Revenue Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Incyte Corporation or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Incyte Corporation and Geron Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Sarepta Therapeutics, Inc. vs Perrigo Company plc
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.